The global bioreactors market is expected to grow at a CAGR of 6.8%. The study on global bioreactors market includes volume market for stainless steel, single-use and glass bioreactors. Factors such as the increase in adoption of single-use technologies, use of hybrid technologies: single-use and stainless steel, growing popularity of single-use bioreactor among biopharmaceutical companies, and growing biologics market are fueling the growth of this market.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=59253123
This report mainly considers three types of bioreactor material Glass, stainless steel, and single-use bioreactors. Glass bioreactors are majorly used for R&D and scaling up process development. They are also used in academic and research institutes. The single-use segment commanded around 41% of the global bioreactors market, in terms of volume. The large percentage of this segment is attributed to the widespread usage of single-use bioreactors across clinical and commercial production.
In this report, the bioreactors market is segmented into four major geographic segments, namely, North America, Europe, Asia-Pacific, and Rest of the World. In terms of volume, North America accounted for 42% of the total bioreactors market, by region. Asia-Pacific countries are expected to show the highest growth, being emerging markets for bioreactors owing to the expansion of the biopharmaceutical sector in this region. China, for instance, is the most preferred destination for leading biopharma companies for the production of biologics, and has attracted significant investment in this field.
This research study is aimed at identifying emerging trends and opportunities in the global bioreactors market along with detailed classifications, in terms of revenue. It provides comprehensive competitive landscape and identifies the key players with respect to percentage share. The research study also includes a detailed segmentation of the global bioreactors market, on the basis of end-user, usage, scale, material, control type, and suppliers.
The major players operating in global bioreactor market include Sartorius AG (Germany), Thermo Fisher Scientific, Inc. (U.S.), Merck KGaA (Germany), GE Healthcare (A subsidiary of General Electric Company) (U.S.), Danaher Corporation (U.S), Eppendorf AG (Germany), and major EPC players included in this report are Amec Foster Wheeler plc (U.K.), Fluor Corporation (U.S.), Jacobs Engineering Group Inc. (U.S.), M+W Group (Germany), PM Group (Ireland), and Technip S.A. (France).
Request Free Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=59253123
The global bioreactor market is fragmented and competitive, with a significant number of global and regional market players. This segment studies the growth strategies adopted by key market players between 2013 and 2016. Leading players in the bioreactor market have adopted various strategies to expand their global presence and increase their market shares. New product launches, FDA approval, and acquisitions are some of the key strategies adopted by the market players to achieve growth in the bioreactor market.
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441